These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mitoxantrone (novantrone): a review of experimental and early clinical studies. Smith IE Cancer Treat Rev; 1983 Jun; 10(2):103-15. PubMed ID: 6347376 [No Abstract] [Full Text] [Related]
5. Mitoxantrone as first line cytotoxic therapy in advanced breast cancer: preliminary results of a phase II study. Mouridsen HT; Rose C; Nooy MA; van Oosterom AT Cancer Treat Rev; 1983 Dec; 10 Suppl B():47-52. PubMed ID: 6661734 [TBL] [Abstract][Full Text] [Related]
6. Mitoxantrone versus doxorubicin in advanced breast cancer: a randomized cross-over trial. Neidhart JA; Gochnour D; Roach RW; Steinberg JA; Young D Cancer Treat Rev; 1983 Dec; 10 Suppl B():41-6. PubMed ID: 6362877 [No Abstract] [Full Text] [Related]
7. Mitoxantrone: an overview of safety and toxicity. Posner LE; Dukart G; Goldberg J; Bernstein T; Cartwright K Invest New Drugs; 1985; 3(2):123-32. PubMed ID: 3894276 [TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy with cyclophosphamide, mitoxantrone and 5-fluorouracil in patients with metastatic breast cancer. Yap HY; Esparza L; Blumenschein GR; Hortobagyi GN; Bodey GP Cancer Treat Rev; 1983 Dec; 10 Suppl B():53-5. PubMed ID: 6661735 [No Abstract] [Full Text] [Related]
13. Potential cardiotoxicity with mitoxantrone. Schell FC; Yap HY; Blumenschein G; Valdivieso M; Bodey G Cancer Treat Rep; 1982 Aug; 66(8):1641-3. PubMed ID: 7105054 [TBL] [Abstract][Full Text] [Related]
14. Mitoxantrone (Novantrone) as single agent and in combination chemotherapy in the treatment of advanced breast cancer. Smith IE; Stuart-Harris R; Pavlidis N; Bozek T Cancer Treat Rev; 1983 Dec; 10 Suppl B():37-40. PubMed ID: 6661733 [TBL] [Abstract][Full Text] [Related]
15. First-line mitoxantrone chemotherapy for advanced breast cancer. Wilson KS; Paterson AH Cancer Treat Rep; 1986 Aug; 70(8):1021-2. PubMed ID: 3731148 [TBL] [Abstract][Full Text] [Related]
16. Sequential studies on the role of mitoxantrone in the treatment of acute leukaemia. Prentice HG; Robbins G; Ma DD; Ho AD Cancer Treat Rev; 1983 Dec; 10 Suppl B():57-63. PubMed ID: 6362878 [TBL] [Abstract][Full Text] [Related]
17. Disposition of mitoxantrone in patients. Alberts DS; Peng YM; Leigh S; Davis TP; Woodward DL Cancer Treat Rev; 1983 Dec; 10 Suppl B():23-7. PubMed ID: 6661732 [No Abstract] [Full Text] [Related]
18. Heart of darkness: the downside of trastuzumab. Hayes DF; Picard MH J Clin Oncol; 2006 Sep; 24(25):4056-8. PubMed ID: 16908930 [No Abstract] [Full Text] [Related]
19. Sequential studies on the role of mitoxantrone in the treatment of acute leukemia. Prentice HG; Wimperis JZ; Robbins G Invest New Drugs; 1985; 3(2):207-12. PubMed ID: 3894280 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of mitoxantrone cardiac toxicity by nuclear angiography and endomyocardial biopsy: an update. Benjamin RS; Chawla SP; Ewer MS; Carrasco CH; Mackay B; Holmes F Invest New Drugs; 1985; 3(2):117-21. PubMed ID: 4019116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]